Insights on Discovery

  1. Use Of Epiontis ID In A Phase 2 Psoriasis Trial 9/25/2025

    Mirikizumab’s Phase 2 trial explores IL-23 inhibition in psoriasis, measuring immune cell changes to assess its potential for long-term disease control and flare-up prevention.

  2. How AI & Biomarkers Are Reshaping The Next Frontier In Drug Development 9/18/2025

    Learn more about the importance of biomarker-driven drug development and the integration of laboratory science, clinical expertise, and regulatory strategy to accelerate targeted therapy development.

  3. Enhancing Throughput And Reproducibility In Proteomic Analysis 8/27/2025

    Streamline proteomic workflows with consistent sample preparation. Discover how simplifying LC-MS processes can eliminate bottlenecks, improve reproducibility, and accelerate drug discovery research.

  4. Improving The Efficiency And Quality Of Advanced Imaging And Analysis 8/27/2025

    Human-relevant models are transforming drug screening. Find out how overcoming 3D cell culture challenges with integrated innovations accelerates discovery and brings effective treatments to patients faster.

  5. Variant-Aware Off-Target Analysis For Informed Guide RNA Selection 8/5/2025

    See how a multi-step, variant-aware approach to CRISPR-based guide RNA selection systematically reduces off-target risk at each stage, giving researchers greater confidence in their work.

  6. ASCO 2025: Key Takeaways From The American Society Of Clinical Oncology Annual Meeting 7/31/2025

    Cell and gene therapy for cancer continues to advance. New data show promise, alongside discussions on safety and scalability.

  7. Detect Rare, Low-Expressing BCMA CAR-T Cells In One Step 7/31/2025

    Discover how precise flow cytometric identification of CAR+ cells across diverse models and workflows enables high specificity, flexibility, and sensitivity—even in rare or low-expression populations.

  8. Rapid Production Of Assay Ready Cells For GPCR Drug Discovery 7/29/2025

    Accelerate drug discovery by leveraging transiently transfected assay-ready cells. This method improves assay sensitivity and reduces variability for GPCRs.

  9. A Novel Cell-Based Assay For Ubiquitin Drug Discovery 7/29/2025

    Learn about a novel cell-based assay that can advance ubiquitin ligase drug discovery. This high-throughput method simplifies assay development, saving time and resources.

  10. High-Throughput Screening Of Ion Channel Variants Using Automated Patch Clamp Recordings In Assay Ready Cells 7/29/2025

    High-throughput screening of KCNQ2 ion channel variants provides insights into epilepsy and treatment responses. This validated method supports rapid characterization for precision medicine.